Literature DB >> 24602394

Salvage thoracic surgery in patients with primary lung cancer.

Hidetaka Uramoto1, Fumihiro Tanaka2.   

Abstract

BACKGROUND: Patients with advanced non-small cell lung cancer (NSCLC) continue to have a poor prognosis. The majority of patients are not indicated for surgery for a radical cure, and systemic chemotherapy is the mainstay of treatment. However, long-term survival is rare due to the resistance to therapy. On the other hand, surgery is performed only under certain conditions for colon cancer and esophageal cancer. Few reports are available about salvage thoracic surgery in patients with primary lung cancer. The purpose of this study was to show the outcomes of salvage surgery for lung cancer, and we discuss possible future treatment strategies based on our findings.
METHODS: Three hundred and fifty-two patients with primary lung cancer underwent surgical resection, and we evaluated those who underwent salvage operations. We also examined the relationships between the performance of a salvage operation and the clinicopathological characteristics of the patients. The clinical outcomes of salvage surgery for lung cancer were assessed.
RESULTS: Salvage thoracic operations were performed in eight (2.3%) of the 352 patients. The surgical procedures were lobectomy in four patients, segmentectomy in two, and pneumonectomy and wedge resection were each performed in one patient. There was no postoperative mortality. All patients were alive at the time of the analysis. The mean follow-up period for the salvage operation cases was 14.0 months. No significant correlation was identified between the incidence of salvage surgery and the age, gender, histology, postoperative stay or hospital stay. The incidence of advanced stage disease was higher in the salvage cases than in the overall cases.
CONCLUSIONS: Salvage thoracic surgery was possible, and moderately improved the prognosis, without prolongation of the postoperative stay or hospital stay. A salvage operation might be considered a reasonable and proper treatment for carefully selected patients.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Indication; Lung cancer; Operation; Salvage; Therapeutic effect; Thoracic

Mesh:

Year:  2014        PMID: 24602394     DOI: 10.1016/j.lungcan.2014.02.004

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  We should be done in such a way that patients with stage IV non-small cell lung cancer who would benefit from surgery are not overlooked.

Authors:  Yasuhiro Chikaishi; Ayako Hirai; Naoko Imanishi; Yoshinobu Ichiki; Fumihiro Tanaka
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 2.  Current Topics on Salvage Thoracic Surgery in Patients with Primary Lung Cancer.

Authors:  Hidetaka Uramoto
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-03-04       Impact factor: 1.520

3.  Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?

Authors:  Waldemar Schreiner; Wojciech Dudek; Sebastian Lettmaier; Rainer Fietkau; Horia Sirbu
Journal:  J Cardiothorac Surg       Date:  2016-01-19       Impact factor: 1.637

4.  Salvage thoracic surgery in patients with lung cancer: potential indications and benefits.

Authors:  Erkan Kaba; Mehmet Oguzhan Ozyurtkan; Kemal Ayalp; Tugba Cosgun; Mazen Rasmi Alomari; Alper Toker
Journal:  J Cardiothorac Surg       Date:  2018-01-22       Impact factor: 1.637

5.  Primary pneumonectomy, pneumonectomy after induction therapy, and salvage pneumonectomy: a comparison of surgical and prognostic outcomes.

Authors:  Noriaki Sakakura; Tetsuya Mizuno; Hiroaki Kuroda; Yukinori Sakao
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.